Breast Cancer Research and Treatment

Low-density lipoprotein receptor mRNA in human breast cancer cells: Influence by PKC modulators
pp. 195-205(11)
Authors: Stranzl A.; Schmidt H.; Winkler R.; Kostner G.M.

Distribution of stromelysin-3 mRNA transcripts and microvessels in human breast carcinomas
pp. 207-213(7)
Authors: Linder C.; Engel G.; Auer G.; Strander H.; Linder S.

Mechanism for maintenance of high breast tumor estradiol concentrations in the absence of ovarian function: Role of very high affinity tissue uptake
pp. 215-226(12)
Authors: Masamura S.; Santner S.J.; Gimotty P.; George J.; Santen R.J.

Sex steroid binding protein receptor (SBP-R) is related to a reduced proliferation rate in human breast cancer
pp. 227-234(8)
Authors: Catalano M.G.; Comba A.; Fazzari A.; Benedusi-Pagliano E.; Sberveglieri M.; Revelli A.; Massobrio M.; Frairia R.; Fortunati N.

Post screen-detected breast cancer within the Screening Mammography Program of British Columbia
pp. 235-242(8)
Authors: Hislop T.G.; Worth A.J.; Kan L.; Rousseau E.

Diet and premenopausal bilateral breast cancer: A case-control study
pp. 243-251(9)
Authors: Witte J.S.; Ursin G.; Siemiatycki J.; Thompson W.D.; Paganini-Hill A.; Haile R.W.

Premenopausal node-negative breast cancer: May adjuvant chemotherapy be indicated by the analysis of nuclear DNA dynamics?
pp. 253-263(11)
Authors: Wyss-Desserich M-T.; Caduff-Joos R.; Wyss P.; Rageth C.; Wight E.; Unger C.; Walt H.; Haller U.

Tamoxifen as initial endocrine therapy for metastatic breast cancer: Long term follow-up of two Piedmont Oncology Association (POA) trials
pp. 265-274(10)
Authors: Kuss J.T.; Muss H.B.; Hoen H.; Case L.D.

Assessing emotional distress of women with breast cancer: A survey of surgical oncologists
pp. 275-281(7)
Authors: Trief P.M.; Khan S.

p53 protein expression in ductal carcinoma in situ (DCIS) of the breast
pp. 283-290(8)
Authors: Rajan P.B.; Scott D.J.; Perry R.H.; Griffith C.D.M.